Citius Pharmaceuticals Eulerpool Vijesti

Citius Pharmaceuticals Aktie News

Citius Pharmaceuticals prate mnogi novinari i investitori širom svijeta. Najnovije Citius Pharmaceuticals vijesti prikupljamo ovdje.

• 22. studenoga ·

  Yahoo
  Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split
• 11. studenoga ·

  Yahoo
  Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA®) and LYMPHIR™ in Cancer Patients with Recurrent Solid Tumors
• 26. rujna ·

  Thefly.com
  Biotech Alert: Searches spiking for these stocks today
• 5. rujna ·

  Yahoo
  Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
• 5. rujna ·

  Yahoo
  Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce LYMPHIR™ (Denileukin Diftitox-cxdl) Added to National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology
• 5. rujna ·

  PR Newswire
  Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce LYMPHIR? (Denileukin Diftitox-cxdl) Added to National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology
• 19. kolovoza ·

  Thefly.com
  Citius Pharmaceuticals selloff since spinout an opportunity, says EF Hutton
• 16. kolovoza ·

  TipRanks
  Buy Rating Affirmed for Citius Pharmaceuticals Amid Strategic Oncology Spinout and Promising Lead Product Data
• 13. kolovoza ·

  Yahoo
  Sidoti Events, LLC's Virtual August Micro-Cap Conference
• 13. kolovoza ·

  Yahoo
  Citius merges oncology subsidiary with TenX Keane